PMC 3564852
S.WangZ.CajkaT.BuffaJ
Cost-effectiveness improves with: Age (older individuals see more dramatic relative improvement) Baseline deficiency (those with lower starting GH benefit more) Consistent training and nutrition (peptides amplify rather than replace fundamentals) Anti-aging and skin health Cost range: $150-500 monthly Duration: Ongoing or cyclical Cost-effectiveness: Subjective Value depends on how much you prioritize appearance and skin quality

Filed Under: Biologics, Dermatology, Immunology, Infectious Disease, Metabolic disease/endicrinology, Oncology Tagged With: AbbVie, biologic drugs, biosimilar competition, drug sales H1 2025, Eli Lilly, GLP-1 drugs, IL-23 inhibitors, immunology drugs, Keytruda patent expiry, loss of exclusivity, Merck, Novo Nordisk, obesity drugs, Oncology Therapeutics, patent cliff 2028, PD-1 inhibitors, pharmaceutical blockbusters, prescription drug market, Skyrizi, therapeutic categories Brian Buntz As the pharma and biotech editor at WTWH Media, Brian has almost two decades of experience in B2B media, with a focus on healthcare and technology
October 4, 1999